Skip to content
Nouscom

Nouscom

Biotech·United States·Active·3yr hold
Entry
2023
Hold
3yr
Status
Active

Who owns Nouscom?

Nouscom is an American Biotech company, currently owned by Angelini Ventures since 2024 and 4 other investors.

Hand-verified · updated 2026-04-21

Open JSON · CC-BY
Andera Partners
Most recent investor
Andera Partners
BioDiscovery 6 · 2022 · VC
5 ownership periods · full history below

Key facts

HQUnited States
SectorBiotech
Key takeaways
  • ·Co-held by Indaco Venture Partners SGR, Panakes Partners SGR, Andera Partners, XGen Venture SGR and Angelini Ventures since 2017.
  • ·5 distinct PE sponsors across ownership cycles.

Ownership history

5 ownership periods · co-invest detected

Co-invest · 5 holders · 2017 · present
Indaco Venture Partners SGR
2017 · present(9yr) · Indaco Ventures I · 2017 · VC
XGen Venture SGR
2023 · present(3yr) · XGEN Venture Life Sciences Fund · 2022 · Life Sciences VC
Andera Partners
2023 · present(3yr) · BioDiscovery 6 · 2022 · VC
Panakes Partners SGR
2023 · present(3yr) · Panakes Fund Purple · 2021 · Life Sciences VC
Angelini Ventures
2024 · present(2yr) · Angelini Ventures · 2022 · Life Sciences VC

Questions

Who owns Nouscom?

Nouscom is currently owned by Angelini Ventures, Panakes Partners SGR and 3 others, through BioDiscovery 6, since 2024.

When did Angelini Ventures and 4 others acquire Nouscom?

Angelini Ventures and 4 others acquired Nouscom in 2024.

Who has owned Nouscom over time?

Nouscom has been through 5 private-equity ownership periods: Indaco Venture Partners SGR · via Indaco Ventures I · since 2017; Panakes Partners SGR · via Panakes Fund Purple · since 2023; Andera Partners · via BioDiscovery 6 · since 2023; XGen Venture SGR · via XGEN Venture Life Sciences Fund · since 2023; Angelini Ventures · via Angelini Ventures · since 2024.

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue